This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Amgen USA Inc. for the provision of Calcitonin Gene-Related Peptide (CGRP) agents. The single-award contract has a ceiling value of $100,527,333.60 and a period of performance from February 26, 2025, to February 25, 2026, with four one-year option periods.
The contract aims to provide an uninterrupted source of supply for CGRP products to the VA, including its Consolidated Mail Order Pharmacies and State Veterans Homes, the Indian Health Service (IHS), and the Federal Health Care Center. The VA will award task orders for specific CGRP products such as ERENUMAB-AOOE, FREMANEZUMAB-VFRM, and GALCANEZUMAB-GNLM, which will be distributed through the VA's and Department of Defense's Pharmaceutical Prime Vendor Programs. The contract is not set-aside and is open to all responsible sources, with the NAICS code 325412 for Pharmaceutical Preparation Manufacturing.
Generated 1/14/25, 9:06 AM